Navigation Links
Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal
Date:7/1/2011

forced vital capacity (FVC). At day 84, the aggregate mean change from baseline for all patients was 4.5% and 3.5% for relative percent predicted FEV1 and FVC, respectively. Importantly, combined mean improvements in FEV1 and FVC occurred coincident with the greatest mean improvement in total chloride transport and, with the cessation of ataluren treatment, FEV1 and FVC values reverted towards baseline. The study was not powered to detect statistical significance in these outcome measures and observed changes were not statistically significant.

As an additional secondary endpoint, the study evaluated the frequency of CF-related coughing, which is the most common complaint among patients and often interferes with activities of daily living.(3),(4) During the study, quantitative measurements of CF-related coughing were conducted over a 24-hour period after each clinic visit and results showed that ataluren was associated with an aggregate mean reduction in waking cough frequency of 23% for all patients (p=0.006, paired t-test).

Safety results from the study showed that ataluren was generally well tolerated. Most adverse events were mild or moderate and compliance with study drug was greater than 96% for all patients.

The abstract titled "Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis" is available online at: http://erj.ersjournals.com/content/early/2011/01/13/09031936.00120910.abstract?sid=f34afce6-c9f0-4da2-bcb3-708f931ddda2

ABOUT ATALUREN

An investigational new drug discovered by PTC Therapeutics, ataluren (formerly referred to as PTC124®) is a protein restoration therapy designed to enable the formation of a functioning protein in patients with genetic disorders caused by a nonsense mutation. A nonsense mutation is an alteration in the genetic code that prematu
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
2. PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy
3. Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain
4. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
5. DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
6. Phase I of the Swedish/Issaquah Medical Center Campus to Open in July
7. The Lancet Publishes Data from Protege, MacroGenics Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
8. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
9. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
10. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
11. Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014  AVT, Inc. ... in automated retailing, micro-stores, custom vending machines and ... their automated medicine dispensing systems, which can be ... clinics and marijuana dispensaries. AVT,s newly designed systems ... of medicines and regulated products. "We ...
(Date:7/21/2014)... 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... Administration (FDA) accepted the company,s Investigational New Drug (IND) ... and efficacy of AVP-786, Avanir,s next generation compound. The ... the adjunctive treatment of major depressive disorder (MDD) during ... "The endorsement of this Phase II study by the ...
(Date:7/21/2014)... July 21, 2014   Aventura , the leader ... announced today that MemorialCare Health System , ... computing solution at the Orange Coast Memorial ... Orange Coast Memorial is a 218-bed ... 12,000 patients annually. The Aventura Roaming Aware Desktop ...
Breaking Medicine Technology:Technology Driving Cannabis Industry 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 3MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 4
... Patent Office has awarded COPAN the much awaited patent for ... samples. This grant, deriving from a very thorough and careful ... flocked swab invention. COPAN,s revolutionary invention has now been awarded ...   " We are thrilled to receive ...
... -- The Ministry of Health and Welfare (Minister ... Institute (President Ko Kyung-hwa) launched a project to ... by designating 38 tasks, including seven major issues ... injuries and granting permission for drug dispensing in ...
Cached Medicine Technology:US Patent Office Grants COPAN Invention of Flocked Swabs 2Medical Korea's Medical Policy Improvement Project for Foreign Patients 2
(Date:7/22/2014)... Get Real Health announced today ... (IDF) to provide their patient community with a ... to electronically track their symptoms, medications and other health-related ... also allow those patients and families who want ... data shared with the U.S. Immunodeficiency Network (USIDNET) ...
(Date:7/22/2014)... July 22, 2014 Atreo Services will ... service and support programs and accessories in booth #1423 ... Conference & Technical Exhibition in Chicago, Ill., Aug. 3-6. ... pneumatic tube system carriers as well as its selection ... brand-name hospital tube systems. In addition, representatives will ...
(Date:7/22/2014)... Altec Products, Inc. , a leader ... their Gold Sponsorship of Sage Summit 2014 ... and Casino in Las Vegas, Nevada. The largest educational ... in taking advantage of the many opportunities to network ... and educate themselves on the latest enterprise resource planning ...
(Date:7/22/2014)... Dr. Allen Kamrava, colorectal surgeon in Beverly ... new website dedicated to the diagnosis and treatment of ... DrKamrava.com . , “With this new website, I ... trustworthy source for various colorectal conditions ,” says ... colon cancer, hernias, or more, patients will find that ...
(Date:7/22/2014)... FL (PRWEB) July 22, 2014 ... opened registration for multiple upcoming real estate investing workshops ... potentially life-changing events are designed to introduce people to ... in the Canadian market. , A total of 9 ... a period of three weeks. The goal is to ...
Breaking Medicine News(10 mins):Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 2Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 3Health News:Brick Buy Brick Announces Multiple 1-Day Real Estate Workshops Coming to Toronto 2
... Calif., April 1, 2008 MAQUET Cardiovascular,LLC ... infringement complaints,in the United States International Trade ... District of Northern California against Terumo Corporation,and ... that,Terumo infringes two MAQUET U.S. patents through ...
... have found that community health center-trained family physicians were ... non-community health center-trained counterparts (64 percent versus 37 percent), ... of Family Medicine. The news comes on the heels ... Program that there is an increased interest in family ...
... College of Cardiology during,ceremonies at the 57th Annual ... CHICAGO, April 1, 2008 Robert O. Bonow, ... Northwestern Memorial Hospital, and Goldberg Distinguished Professor of,Northwestern ... the,American College of Cardiology (ACC) as Master of ...
... 1, 2008 Faced with shrinking,staffs and less ... time serving the hospital marketplace. As their time,to ... for the,pharma industry are turning to other decision-makers ... formularies, according to research from benchmarking,leader Best Practices, ...
... for Heightened Autism Awareness among Hispanic Community as Fewer ... Receiving Diagnosis and Support, ... its services for individuals living with autism, among the,vast array of ... ones., Over the last 20 years, Easter Seals has seen ...
... Co-Chairs and Leading Grassroots Autism Association Push,for Services ... The United,Nations has designated April 2 as World ... Autism Society of America, the World Autism,Organization and ... Research and Education (C.A.R.E.), Rep. Chris Smith and ...
Cached Medicine News:Health News:MAQUET Cardiovascular Announces Patent Infringement Complaints Against Terumo 2Health News:Want docs to treat the underserved? Make sure they train at community health centers 2Health News:Robert Bonow, MD Honored for Outstanding Service by the American College of Cardiology 2Health News:Robert Bonow, MD Honored for Outstanding Service by the American College of Cardiology 3Health News:Effectively Influencing the Hospital Marketplace to Win a Place on Formularies 2Health News:Easter Seals Notes April's Autism Awareness Month to Highlight Services Available to Families Living With Autism 2Health News:Easter Seals Notes April's Autism Awareness Month to Highlight Services Available to Families Living With Autism 3Health News:Reps. Smith and Doyle, Autism Society of America Push Landmark Legislation on World Autism Awareness Day 2Health News:Reps. Smith and Doyle, Autism Society of America Push Landmark Legislation on World Autism Awareness Day 3
... facilitates real time information collection. It ... first module is a software link ... the database where information is captured ... the user interface, which allows access ...
... provides a solution for instantaneously locating ... or unauthorized movement of patients or ... key concern. Certain patients, such as ... patients with highly communicable diseases, patients ...
... PDC Smart™ Labels have a direct ... Texas Instruments Tag-it™ HF-I transponder. When ... codes, text and other graphics may ... variable data is programmed to the ...
PDC RFID Smart™ Cards can be printed and programmed using a dye-sublimation card printer & programmer....
Medicine Products: